FdaApplication
ANDA 207625
Identifiers
- fda_app_no: ANDA207625
Properties
| Property | Value |
|---|---|
| applicant_name | LUOXIN AUROVITAS PHARMA CHENGDU CO LTD |
| application_type | ANDA |
| approval_date | 2016-12-30 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | EQ 0.0103% BASE | SOLUTION;INHALATION |
| LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | EQ 0.042% BASE | SOLUTION;INHALATION |
| LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | EQ 0.021% BASE | SOLUTION;INHALATION |
3 products